BackFirst Tracks Biotherapeutics Ordinary Shares When-Issued Overview

First Tracks Biotherapeutics Ordinary Shares When-Issued Receivables

Track First Tracks Biotherapeutics Ordinary Shares When-Issued's receivables ($2.9M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$2.87M

Peer trimmed avg / median

Loading

First Tracks Biotherapeutics Ordinary Shares When-Issued Receivables History

Loading

First Tracks Biotherapeutics Ordinary Shares When-Issued vs. peers: Receivables Comparison

Loading

First Tracks Biotherapeutics Ordinary Shares When-Issued Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

First Tracks Biotherapeutics Ordinary Shares When-Issued (TRAXV) FAQ

First Tracks Biotherapeutics Ordinary Shares When-Issued (TRAXV) currently reports a receivables of $2.9M as of September 2026. Use the charts on this page to explore First Tracks Biotherapeutics Ordinary Shares When-Issued's receivables history and peer comparisons.

First Tracks Biotherapeutics Ordinary Shares When-Issued reported $2.9M in receivables as of September 2026. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $2.9M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for First Tracks Biotherapeutics Ordinary Shares When-Issued, and consider following TRAXV for alerts when major investors trade the stock.

First Tracks Biotherapeutics Ordinary Shares When-Issued is classified in the Healthcare sector. On receivables, it currently shows $2.9M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing TRAXV with unrelated industries.